US 9815890
Antibodies to the C3d fragment of complement component 3
granted A61PA61P1/04A61P1/16
Quick answer
US patent 9815890 (Antibodies to the C3d fragment of complement component 3) held by The Regents of the University of Colorado, a Body Corporate expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P1/04, A61P1/16, A61P1/18, A61P11/00